To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT03752099 · TERMINATED
Trial details
- NCT number
- NCT03752099
- Sponsor
- Veru Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-18
- Primary completion
- 2023-03-15
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.